The Effects of 12-Week Beta-Hydroxy-Beta-Methylbutyrate Supplementation in Patients with Liver Cirrhosis: Results from a Randomized Controlled Single-Blind Pilot Study

by Barbara Lattanzi, Angelo Bruni, Simone Di Cola, Alessio Molfino, Adriano De Santis, Maurizio Muscaritoli, Manuela Merli
Published 2021-07-01

The Effect of 12 Weeks of β-Hydroxy-β-Methyl-Butyrate Supplementation after Liver Transplantation: A Pilot Randomized Controlled Study

by Barbara Lattanzi, Michela Giusto, Carlina Albanese, Gianluca Mennini, Daria D’Ambrosio, Alessio Farcomeni, Stefano Ginanni Corradini, Massimo Rossi, Manuela Merli
Published 2019-09-01

The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey.

by Manuela Merli, Cristina Lucidi, Vincenza Di Gregorio, Marco Falcone, Valerio Giannelli, Barbara Lattanzi, Michela Giusto, Giancarlo Ceccarelli, Alessio Farcomeni, Oliviero Riggio, Mario Venditti
Published 2015-01-01

Donor Small-Droplet Macrovesicular Steatosis Affects Liver Transplant Outcome in HCV-Negative Recipients

by Flaminia Ferri, Quirino Lai, Antonio Molinaro, Edoardo Poli, Lucia Parlati, Barbara Lattanzi, Gianluca Mennini, Fabio Melandro, Francesco Pugliese, Federica Maldarelli, Alessandro Corsi, Mara Riminucci, Manuela Merli, Massimo Rossi, Stefano Ginanni Corradini
Published 2019-01-01

Cumulative incidence of solid and hematological De novo malignancy after liver transplantation in a multicentre cohort

by Cristina Lucidi, Marco Biolato, Quirino Lai, Barbara Lattanzi, Ilaria Lenci, Martina Milana, Raffaella Lionetti, Antonio Liguori, Mario Angelico, Giuseppe Tisone, Alfonso Wolfango Avolio, Salvatore Agnes, Massimo Rossi, Antonio Grieco, Manuela Merli
Published 2021-09-01